Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02274012
Title Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment of HER2 Amplified Advanced Gastric, Gastroesophageal Junction and Esophageal Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Balazs Halmos
Indications

gastroesophageal junction adenocarcinoma

esophageal carcinoma

stomach carcinoma

Therapies

Afatinib + Paclitaxel

Age Groups: adult
Covered Countries


No variant requirements are available.